top of page
TURNING OUR VISION IN TO HEALTH
Global Pharmaceutical News
BrainStorm Builds NurOwn’s Case in ALS with Biomarker Data
Friday, BrainStorm Cell Therapeutics posted positive Phase III data for its amyotrophic lateral sclerosis candidate NurOwn, showing that the
Quantung Pharmaceutical Export company
CRISPR on the Cusp: The Promise and the Pain Points
angioedema patients treated with Intellia’s NTLA-2002—an in vivo CRISPR-Cas9 therapy— had an average 95% reduction in the sudden, debilitati
Quantung Pharmaceutical Export company
BMS’ Sotyktu gets NICE green light for NHS use
The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults
Quantung Pharmaceutical Export company
King’s College London and Pioneer Group in incubator link-up
Pioneer Group has announced a partnership with King’s College London to launch new dedicated start-up incubators in biotech and medtech on t
Quantung Pharmaceutical Export company
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
Johnson & Johnson has capitalized on the shaky financial ground at French biotech Nanobiotix by licensing its lead product, NBTXR3, intended
Quantung Pharmaceutical Export company
BeiGene Ups ADC Investment with $1.3B DualityBio Licensing Deal
Chinese biotech BeiGene has acquired an exclusive license of an investigational antibody-drug conjugate for $1.3 billion from Shanghai-based
Quantung Pharmaceutical Export company
Edinburgh researchers and LifeArc to boost MND treatment processes
A project involving researchers based in Edinburgh wants to establish effective combinations of existing drugs which, used together, could t
Quantung Pharmaceutical Export company
TME Pharma reveals positive NOX-A12 data
GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients
TME Pharma – a company concentrating on the develo
Quantung Pharmaceutical Export company
Digital Health London’s Accelerator programme selects Aide
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions
Quantung Pharmaceutical Export company
University of Oxford and PrecisionLife reach data agreement
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis
Quantung Pharmaceutical Export company
Genfit and Ipsen announce elafibranor results
ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint
Quantung Pharmaceutical Export company
Teva reveals critical Ajovy data
Therapy has been developed to reduce the frequency, duration and severity of migraine attacks
Quantung Pharmaceutical Export company
Momentum for Poolbeg and CytoReason’s AI collaboration
Partnership establishes several influenza therapy targets using artificial intelligence
Quantung Pharmaceutical Export company
Novartis reveals five-year efficacy data for Kesimpta
Patients treated with Kesimpta experienced considerable decreases in relapse rates
Quantung Pharmaceutical Export company
GeneCode receives record Parkinson’s funding
European Innovation Council Accelerator finances treatment development drive for condition
Quantung Pharmaceutical Export company
Positive efficacy data for Sensorian’s candidate I QUANTUNG Pharma
SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation
Quantung Pharmaceutical Export company
Incyte’s Opzelura gets MHRA authorisation
Incyte Biosciences has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for
Quantung Pharmaceutical Export company
Vertex’s Orkambi receives EC approval I QUANTUNG Pharma
Orkambi is an oral treatment for very young children that combines both lumacaftor and ivacaftor
Quantung Pharmaceutical Export company
Partners
bottom of page